Skip to main content
. 2024 Sep 19;9(39):41032–41042. doi: 10.1021/acsomega.4c06604

Table 7. Noncompartmental Pharmacokinetic Parameter of HHC at Dose 40 mg/kg after Oral/IP Administration in Mice (n = 4).

PK parameters AUC0–t (ng·min/mL) AUC0–∞ (ng·min/mL) MRT0–t (min) MRT0–∞ (min) T1/2 (min) Cmax (ng/mL) Tmax (min)
oral-plasma 7610.4 ± 1906.9 8545.1 ± 2044.9 96.8 ± 29.0 154.7 ± 49.6 130.2 ± 32.1 194.2 ± 43.5 15.0 ± 0.0
IP-plasma 61 967.7 ± 1759.6 62 838.2 ± 16 997.4 42.5 ± 28.7 52.5 ± 28.3 91.2 ± 15.3 9299.0 ± 4286.9 5.0 ± 0.0
IP-liver 572 497.7 ± 270 586.6 576 329.6 ± 272 103.4 156.2 ± 39.4 160.1 ± 35.8 104.5 ± 25.8 25 043.3 ± 12 061.5 5.0 ± 0.0
IP-kidney 37 213.4 ± 12 705.8 38 922.3 ± 14 659.8 96.3 ± 20.6 116.5 ± 37.4 101.7 ± 37.4 1703.0 ± 897.2 6.3 ± 2.5
IP-brain 1120.8 ± 439.8 1267.5 ± 507.2 62.9 ± 64.2 122.5 ± 91.9 106.1 ± 58.8 120.2 ± 54.1 5.0 ± 0.0

Area under the concentration–time curve (AUC) computed from time zero to the time of the last positive t value (AUC0–t); AUC from time zero extrapolated to infinity (AUC0–∞); mean residence time when the drug concentration is based on values up to and including the last measured concentration (MRT0–t); MRT from time zero extrapolated to infinity (MRT0–∞); elimination half-life (T1/2); maximum observed drug concentration (Cmax); and time of maximum concentration (Tmax). All of the HHC PK values are listed as the mean value ± SD. Each mean ± SD (n = 4) is represented by each point.